Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vir Biotechnology, Inc. | 230,712 | reported | 23 Feb 2023 | tx 18+331,111−107,065 |
| Ultragenyx Pharmaceutical Inc. | 105,689 | reported | 01 Jun 2026 | tx 20+419,017−45,864 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 4,653 | 23.77 USD | 10b5-1 |
| 01 May 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 4,683 | 24.90 USD | 10b5-1 |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 34,674 | 0.00 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 59,952 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 5,290 | 22.80 USD | |
| 03 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 1,635 | 22.40 USD | |
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 3,119 | 22.54 USD | |
| 01 Mar 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 6,143 | 0.00 USD | |
| 02 Feb 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 3,061 | 23.56 USD | |
| 02 Jan 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 3,150 | 22.84 USD | |
| 10 Dec 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 3,081 | 36.38 USD | |
| 13 Oct 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 7,942 | 31.51 USD | |
| 06 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 1,785 | 40.40 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 15,653 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 28,160 | 0.00 USD | deriv |
| 10 Oct 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 7,465 | 52.76 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 19,400 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 34,200 | 0.00 USD | deriv |
| 09 Oct 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 80,366 | 0.00 USD | |
| 09 Oct 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 140,469 | 0.00 USD | deriv |
| 23 Feb 2023 | SALE | Vir Biotechnology, Inc. | 2,248 | 25.97 USD | |
| 17 Feb 2023 | SALE | Vir Biotechnology, Inc. | 2,424 | 25.29 USD | |
| 22 Feb 2022 | GRANT_AWARD | Vir Biotechnology, Inc. | 35,000 | 0.00 USD | |
| 22 Feb 2022 | GRANT_AWARD | Vir Biotechnology, Inc. | 50,000 | 0.00 USD | deriv |
| 17 Feb 2022 | SALE | Vir Biotechnology, Inc. | 2,393 | 31.93 USD |